Skip to main content
Clinical Trials/NL-OMON55503
NL-OMON55503
Recruiting
Not Applicable

Tau PET imaging in cognitively normal elderly subjects: A twin approach - Tau Twin

Vrije Universiteit Medisch Centrum0 sites80 target enrollmentTBD

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Alzheimer's disease
Sponsor
Vrije Universiteit Medisch Centrum
Enrollment
80
Status
Recruiting
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
last year
Study Type
Observational invasive

Investigators

Eligibility Criteria

Inclusion Criteria

  • Inclusion in PreclinAD study (2014\.210\) and a subject must be older than 60
  • years, have received an \[18F]flutemetamol amyloid PET scan and/or have a known
  • amyloid status obtained from CSF.

Exclusion Criteria

  • 1\.Has contra indications for MRI scanning and therefore has not received brain
  • 2\.Has evidence of structural abnormalities such as major stroke or mass on MRI
  • that is likely to interfere with interpretation of PET scan;
  • 3\.Has a relevant history of severe drug allergy or hypersensitivity. Relevant
  • severe drug allergies should be determined by the Principal Investigator or
  • Co\-Principal Investigator, and any questions about a subject\*s eligibility can
  • be directed to Avid Radiopharmaceuticals Inc.;
  • 4\.Has ever participated in an experimental study with a tau agent, unless it
  • can be documented that the subject received only placebo during the course of
  • 5\.Has been injected with a previously administered radiopharmaceutical within 6

Outcomes

Primary Outcomes

Not specified

Similar Trials